Insider · CIK 0001034320
Michael D Wortley
Files at RETA (REATA PHARMACEUTICALS INC). First filing Mar 6, 2023, latest Mar 8, 2023.
In brief
Michael D Wortley files SEC Form 4 as officer at RETA (REATA PHARMACEUTICALS INC). Since Mar 6, 2023, Michael D Wortley has reported 0 open-market buys worth $0 and 2 open-market sells worth $225k, the latest filed on Mar 8, 2023.
A track record needs three past buys with six months of prices behind them; Michael D Wortley has 0, so none is measured yet.
The newest scored trade: sold $35k of RETA on Mar 7, 2023, filed Mar 8, 2023, scored 36 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | REATA PHARMACEUTICALS INC | $35k 414 shares | -1% | - | |
| 42Moderate | REATA PHARMACEUTICALS INC | $190k 2,169 shares | -4% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 7, 2023 | RETA REATA PHARMACEUTICALS INC | SOpen-market sale Class A common stock | -414 | $84.46 | $35k | 48,092 | Mar 8, 2023 |
| Mar 3, 2023 | RETA REATA PHARMACEUTICALS INC | SOpen-market sale Class A common stock | -2,169 | $87.57 | $190k | 48,506 | Mar 6, 2023 |
| Jan 3, 2023 | RETA REATA PHARMACEUTICALS INC | AGrant or award Class A common stock | +15,675 | $0.00 | $0 | 50,675 | Jan 4, 2023 |
| Jan 3, 2023 | RETA REATA PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right-to-buy)derivative | +63,650 | $0.00 | $0 | 63,650 | Jan 4, 2023 |
Questions about Michael D Wortley
Answered from the filings on this page, as of the latest one.
Is Michael D Wortley buying or selling?
Not in the last 12 months. Michael D Wortley's latest open-market trade on SEC Form 4 was sold $35k of RETA on Mar 7, 2023.
How did Michael D Wortley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael D Wortley has 0.
Where does Michael D Wortley file Form 4?
Michael D Wortley has filed Form 4 at RETA (REATA PHARMACEUTICALS INC) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.